Alphamir

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug NameAlphamir
Drug Alias Nametrioxolane derivative
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsArthritis, RheumatoidHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesBiochem Solutions
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBiochem Solutions
Active IndicationsN/A
Inactive IndicationsArthritis, RheumatoidHIV Infections

Other Information

ATC CodeN/A
Related LinksN/A